Newsmeme!
Discover News you didn't know existed
Shareholder-friendly stocks that have been marked to underperform the market.
Tasigna front-line data demonstrating potential in newly diagnosed patients with a life-threatening type of leukemia to be featured in two oral sessions at ASH
Allos Therapeutics, Inc. (NASDAQ:ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that it will host an analyst and investor briefing in conjunction with the 50 th Annual Meeting of the American Society of Hematology (ASH) from 6:00 p.m. to 8:00 p.m. (Pacific) on Monday, December 8, 2008.
Allos Therapeutics, Inc. (Nasdaq:ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to the Company's novel antifolate, pralatrexate (PDX), for the treatment of patients with follicular lymphoma.
The National Comprehensive Cancer Network said Tuesday it has received a $1 million research grant from Merck & Co. Inc. to fund clinical trials of new combination treatments for cancer patients. (MRK)
FORT WASHINGTON, Pa.----The National Comprehensive Cancer Network recently received a $1M research grant from Merck & Co., Inc. to fund clinical trials focusing on innovative combinations of vorinostat with radiation/chemoradiation preferentially for patients with selected locally advanced non-metastatic cancers and areas of unmet medical need.
Allos Therapeutics Inc. said Monday federal regulators have granted for the second time in a week a special status to the cancer drug pralatrexate
(AP:WESTMINSTER, Colo.) Allos Therapeutics Inc. said Monday federal regulators have granted for the second time in a week a special status to the cancer drug pralatrexate that protects it from competition if approved.
WESTMINSTER, Colo.----Allos Therapeutics, Inc. , a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S.
Multiple lymphomatous polyposis (MLP) is an unusual form mantle cell lymphoma characterized by polyps throughout the gastrointestinal tract. Adult T-cell leukemia/lymphoma (ATLL) is a malignancy associated with retrovirus, human T-cell lymphotropic virus type 1 (HTLV-1). Although it is well-known that ATLL cells infiltrate into systemic organs including gastrointestinal (GI) tract, colonic ...
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |